Janus Henderson Group PLC
- SEC CIK
- 0001274173
- Latest filing
- May 18, 2026
AVXL holding history
Anavex Life Sciences Corp. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVXL overviewAll 13F holders of AVXLFull Q1 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −37,000−100.0% | Sold out | Holders |
| Q4 2025 | 37,000 | $131.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 37,000 | $329.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 37,000 | $341.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 37,000 | $322.5K | <0.1% | +37,000 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −32,213−100.0% | Sold out | Holders |
| Q1 2024 | 32,213 | $163.8K | <0.1% | +40.0% | Added | Holders |
| Q4 2023 | 32,209 | $300.0K | <0.1% | −64−0.2% | Reduced | Holders |
| Q3 2023 | 32,273 | $211.5K | <0.1% | +80.0% | Added | Holders |
| Q2 2023 | 32,265 | $262.2K | <0.1% | −25−0.1% | Reduced | Holders |
| Q1 2023 | 32,290 | $277.0K | <0.1% | +18,720+138.0% | Added | Holders |
| Q4 2022 | 13,570 | $125.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 13,570 | $140.0K | <0.1% | +23+0.2% | Added | Holders |
| Q2 2022 | 13,547 | $136.0K | <0.1% | −10−0.1% | Reduced | Holders |
| Q1 2022 | 13,557 | $167.0K | <0.1% | +13,557 | New | Holders |